<DOC>
	<DOCNO>NCT01855529</DOCNO>
	<brief_summary>After surgery breast cancer , prevalence chronic pain estimate 20 68 % . They begin surgery may persist 6 month . They respond poorly opioid analgesic impair quality life . Among different postoperative analgesic technique use , use local anesthetic infiltration continue catheter advantage include improve quality analgesia , significant decrease average VAS ( scale visual Analogue ) , decrease morphine consumption , improve quality life patient . Our study aim evaluate effectiveness continuous local anesthetic infiltration control postoperative pain mastectomy .</brief_summary>
	<brief_title>ROPI Study : Ropivacaine Interest Postsurgical Pain After Mastectomy</brief_title>
	<detailed_description />
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>Age &gt; 18 year ASA III , WHO 01 mastectomy alone , mastectomy + GGS + mastectomy CA No previous history chronic pain require regular intake analgesic longterm Failure take opioids within 30 day surgery Longterm treatment analgesic take opioids within 30 day surgery Concurrent treatment drug test , participation another therapeutic clinical trial within &lt; 30 day proven allergy local anesthetic amide Skin Inflammation Sepsis local Kidney failure , liver failure , severe poorly control diabetes Inability respond assessment pain use visual analogue scale ( VAS ) numerical scale ( FR ) . mastectomy immediate breast reconstruction</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>ropivacaine , pain , mastectomy</keyword>
</DOC>